Nate Crossett

Stock Analyst at Exane BNP Paribas

(1.92)
# 3,071
Out of 4,906 analysts
38
Total ratings
50%
Success rate
0.59%
Average return

Stocks Rated by Nate Crossett

Medical Properties Trust
Mar 12, 2025
Upgrades: Outperform
Price Target: $5$9
Current: $4.03
Upside: +123.33%
Omega Healthcare Investors
Feb 8, 2024
Upgrades: Neutral
Price Target: $30
Current: $38.05
Upside: -21.16%
Agree Realty
Dec 13, 2023
Downgrades: Neutral
Price Target: $64
Current: $71.32
Upside: -10.26%
NETSTREIT
Dec 13, 2023
Downgrades: Neutral
Price Target: $17
Current: $17.98
Upside: -5.45%
Realty Income
Dec 13, 2023
Upgrades: Outperform
Price Target: $63
Current: $56.39
Upside: +11.72%
Alexandria Real Estate Equities
Oct 11, 2023
Initiates: Neutral
Price Target: $108
Current: $78.27
Upside: +37.98%
Ventas
Oct 11, 2023
Initiates: Outperform
Price Target: n/a
Current: $66.44
Upside: -
Digital Realty Trust
Jul 28, 2023
Upgrades: Outperform
Price Target: $138
Current: $177.11
Upside: -22.08%
Prologis
Jul 20, 2023
Upgrades: Outperform
Price Target: $141
Current: $107.86
Upside: +30.73%
Gaming and Leisure Properties
Jun 14, 2023
Initiates: Outperform
Price Target: $63
Current: $46.63
Upside: +35.11%
Initiates: Underperform
Price Target: $42
Current: $42.83
Upside: -1.94%
Initiates: Outperform
Price Target: $41
Current: $32.75
Upside: +25.19%
Initiates: Outperform
Price Target: $29
Current: $30.47
Upside: -4.82%
Initiates: Underperform
Price Target: $74
Current: $61.83
Upside: +19.68%
Initiates: Outperform
Price Target: n/a
Current: $14.72
Upside: -
Initiates: Underperform
Price Target: $9.6
Current: $7.05
Upside: +36.17%
Initiates: Outperform
Price Target: $66
Current: $98.73
Upside: -33.15%
Initiates: Outperform
Price Target: $38
Current: $16.44
Upside: +131.14%
Initiates: Outperform
Price Target: $886
Current: $789.19
Upside: +12.27%
Downgrades: Hold
Price Target: $31$30
Current: $26.36
Upside: +13.81%
Initiates: Buy
Price Target: $21
Current: $13.46
Upside: +56.02%
Downgrades: Hold
Price Target: $21$25
Current: $10.31
Upside: +142.48%
Upgrades: Buy
Price Target: n/a
Current: $35.74
Upside: -